• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与代谢性肝病的尿素和三羧酸循环相关的非侵入性生物标志物。

Noninvasive biomarkers implicated in urea and TCA cycles for metabolic liver disease.

作者信息

Yang Guiyan, Wan Yu-Jui Yvonne

机构信息

College of Veterinary Medicine, China Agricultural University, Beijing, 100193, China.

Department of Pathology and Laboratory Medicine, University of California, Davis, Davis Health. Room 3400B, Research Building III, 4645 2nd Ave, 95817, Sacramento, CA, USA.

出版信息

Biomark Res. 2024 Nov 22;12(1):145. doi: 10.1186/s40364-024-00694-7.

DOI:10.1186/s40364-024-00694-7
PMID:39578903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11583652/
Abstract

Bile acid (BA) and its receptor FXR play crucial roles in metabolism, and dysregulated BA synthesis regulated by hepatic and bacterial enzymes causes metabolic dysfunction-associated steatohepatitis (MASH) and hepatocellular carcinoma (HCC). Moreover, because ~ 75% of hepatic blood is from the gut, liver metabolism is influenced by intestinal bacteria and their metabolites. Thus, we used gut microbiota and metabolites from the urine and serum to uncover biomarkers for metabolic distress caused by Western diet (WD) intake, aging, and FXR inactivity. Hepatic transcriptomes were profiled to define liver phenotypes. There were 654 transcriptomes commonly altered by differential diet intake, ages, and FXR functional status, representing the signatures of liver dysfunction, and 76 of them were differentially expressed in healthy human livers and HCC. Machine learning approaches classified urine and serum metabolites for differential dietary intake and age difference. Additionally, the gut microbiota could predict FXR functional status. Furthermore, FXR was essential for differentiating dietary effects in colonizing age-related gut microbes. The integrated analysis established the relationships between the metabolites and gut microbiota correlated with hepatic transcripts commonly altered by diet, age, and FXR functionality. Remarkably, the changes in metabolites involved in the urea cycle, mitochondrial metabolism, and amino acid metabolism are associated with hepatic dysfunction (i.e. FXF deactivation). Taken together, noninvasive specimens and biomarkers are promising resources for identifying metabolic distress.

摘要

胆汁酸(BA)及其受体FXR在代谢中起关键作用,由肝脏和细菌酶调节的胆汁酸合成失调会导致代谢功能障碍相关脂肪性肝炎(MASH)和肝细胞癌(HCC)。此外,由于约75%的肝血来自肠道,肝脏代谢受肠道细菌及其代谢产物的影响。因此,我们利用肠道微生物群以及尿液和血清中的代谢产物来揭示由西方饮食(WD)摄入、衰老和FXR失活引起的代谢紊乱的生物标志物。对肝脏转录组进行分析以确定肝脏表型。共有654个转录组因不同的饮食摄入、年龄和FXR功能状态而发生改变,代表了肝功能障碍的特征,其中76个在健康人肝脏和HCC中差异表达。机器学习方法对尿液和血清代谢产物进行分类,以区分不同的饮食摄入和年龄差异。此外,肠道微生物群可以预测FXR功能状态。此外,FXR对于区分饮食对与年龄相关的肠道微生物定殖的影响至关重要。综合分析确定了与通常因饮食、年龄和FXR功能而改变的肝脏转录本相关的代谢产物和肠道微生物群之间的关系。值得注意的是,参与尿素循环、线粒体代谢和氨基酸代谢的代谢产物变化与肝功能障碍(即FXF失活)相关。综上所述,非侵入性标本和生物标志物是识别代谢紊乱的有前景的资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b88/11583652/4c1a528bb40d/40364_2024_694_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b88/11583652/4c1a528bb40d/40364_2024_694_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b88/11583652/4c1a528bb40d/40364_2024_694_Fig1_HTML.jpg

相似文献

1
Noninvasive biomarkers implicated in urea and TCA cycles for metabolic liver disease.与代谢性肝病的尿素和三羧酸循环相关的非侵入性生物标志物。
Biomark Res. 2024 Nov 22;12(1):145. doi: 10.1186/s40364-024-00694-7.
2
The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study.法尼酯X受体(FXR)在饮食和年龄影响的代谢变化及肝脏疾病发展中的重要作用:一项多组学研究
Biomark Res. 2023 Feb 18;11(1):20. doi: 10.1186/s40364-023-00458-9.
3
Uncovering the Gut-Liver Axis Biomarkers for Predicting Metabolic Burden in Mice.揭示肠道-肝脏轴生物标志物,以预测小鼠的代谢负担。
Nutrients. 2023 Jul 31;15(15):3406. doi: 10.3390/nu15153406.
4
Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.胆汁酸合成失调引起的肝脏炎症可通过补充丁酸盐逆转。
J Pathol. 2017 Dec;243(4):431-441. doi: 10.1002/path.4983. Epub 2017 Nov 1.
5
Gegen-Qinlian decoction alleviates metabolic dysfunction-associated steatohepatitis by modulating the microbiota-bile acid axis in mice.葛根芩连汤通过调节小鼠肠道菌群-胆汁酸轴减轻代谢功能障碍相关脂肪性肝炎。
J Ethnopharmacol. 2025 May 12;347:119719. doi: 10.1016/j.jep.2025.119719. Epub 2025 Apr 3.
6
Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism.法尼酯X受体信号塑造肠道微生物群并控制肝脏脂质代谢。
mSystems. 2016 Oct 11;1(5). doi: 10.1128/mSystems.00070-16. eCollection 2016 Sep-Oct.
7
FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Strains.FXR 信号介导的胆汁酸代谢对于 菌株缓解胆固醇结石至关重要。
Microbiol Spectr. 2022 Oct 26;10(5):e0051822. doi: 10.1128/spectrum.00518-22. Epub 2022 Aug 29.
8
LZys1 modulates gut microbiota, diminishes ileal FXR-FGF15 signaling, and regulates hepatic function.LZys1调节肠道微生物群,减少回肠FXR-FGF15信号传导,并调节肝功能。
Microbiol Spectr. 2025 Jun 3;13(6):e0171624. doi: 10.1128/spectrum.01716-24. Epub 2025 Apr 17.
9
Activation of gut FXR improves the metabolism of bile acids, intestinal barrier, and microbiota under cholestatic condition caused by GCDCA in mice.肠道FXR的激活可改善由甘氨鹅去氧胆酸(GCDCA)引起的小鼠胆汁淤积条件下的胆汁酸代谢、肠道屏障和微生物群。
Microbiol Spectr. 2025 Apr;13(4):e0315024. doi: 10.1128/spectrum.03150-24. Epub 2025 Feb 21.
10
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.法尼醇 X 受体在代谢性疾病、胃肠道癌和肝癌中的作用。
Nat Rev Gastroenterol Hepatol. 2021 May;18(5):335-347. doi: 10.1038/s41575-020-00404-2. Epub 2021 Feb 10.

本文引用的文献

1
Hierarchical tricarboxylic acid cycle regulation by hepatocyte arginase 2 links the urea cycle to oxidative metabolism.肝细胞精氨酸酶 2 通过分级三羧酸循环调节将尿素循环与氧化代谢联系起来。
Cell Metab. 2024 Sep 3;36(9):2069-2085.e8. doi: 10.1016/j.cmet.2024.07.007. Epub 2024 Aug 7.
2
Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD.用于 MASLD 肝纤维化的新型无创生物标志物组合的开发。
Nat Commun. 2024 May 29;15(1):4564. doi: 10.1038/s41467-024-48956-0.
3
How CLSPN could demystify its prognostic value and potential molecular mechanism for hepatocellular carcinoma: A crosstalk study.
CLSPN 如何揭示其对肝细胞癌的预后价值和潜在分子机制:一项串扰研究。
Comput Biol Med. 2024 Apr;172:108260. doi: 10.1016/j.compbiomed.2024.108260. Epub 2024 Mar 11.
4
Uncovering the Gut-Liver Axis Biomarkers for Predicting Metabolic Burden in Mice.揭示肠道-肝脏轴生物标志物,以预测小鼠的代谢负担。
Nutrients. 2023 Jul 31;15(15):3406. doi: 10.3390/nu15153406.
5
FXR and NASH: an avenue for tissue-specific regulation.FXR 和 NASH:组织特异性调节的途径。
Hepatol Commun. 2023 Apr 14;7(5). doi: 10.1097/HC9.0000000000000127. eCollection 2023 May 1.
6
Transcriptome Analysis of Protection by Dendrobium Nobile Alkaloids (DNLA) against Chronic Alcoholic Liver Injury in Mice.金钗石斛生物碱(DNLA)对小鼠慢性酒精性肝损伤保护作用的转录组分析
Biomedicines. 2022 Nov 3;10(11):2800. doi: 10.3390/biomedicines10112800.
7
27-Hydroxycholesterol promotes metastasis by SULT2A1-dependent alteration in hepatocellular carcinoma.27-羟胆固醇通过 SULT2A1 依赖性改变促进肝癌转移。
Cancer Sci. 2022 Aug;113(8):2575-2589. doi: 10.1111/cas.15435. Epub 2022 Jun 13.
8
Discovery of farnesoid X receptor and its role in bile acid metabolism.法尼酯X受体的发现及其在胆汁酸代谢中的作用。
Mol Cell Endocrinol. 2022 May 15;548:111618. doi: 10.1016/j.mce.2022.111618. Epub 2022 Mar 11.
9
Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome.CYP39A1 的下调可作为肝细胞癌中具有更差临床结局的新型生物标志物。
Oxid Med Cell Longev. 2021 Dec 31;2021:5175581. doi: 10.1155/2021/5175581. eCollection 2021.
10
Blocking hepatocarcinogenesis by a cytochrome P450 family member with female-preferential expression.通过一种具有雌性偏好性表达的细胞色素P450家族成员来阻断肝癌发生。
Gut. 2022 Nov;71(11):2313-2324. doi: 10.1136/gutjnl-2021-326050. Epub 2022 Jan 7.